David Porter ranked 7th in the HealthInvestor PowerFifty, the UK healthcare industry’s most influential leaders
Apposite Capital appoints Anne-Laure Meynier as Investment Manager
Apposite Capital sells Cancer Partners UK to GenesisCare
Apposite Capital wins the “Private Equity Investor of the year” Award
Cancer Partners UK reveals findings from Ground-breaking research into Deep Inspiration Breath-hold (DIBH) Radiotherapy
Apposite sells By the Bridge to Cambian Group
CancerPartnersUK State-of-the-Art diagnostics and treatment centre to open in Kent
